Byetta (exenatide)
Direct answer
What you need to know
Evidence strength: StrongByetta is exenatide, a GLP-1 receptor agonist approved for type 2 diabetes and given as a twice-daily injection. Exenatide, injected twice daily within 60 minutes before the two main meals — the oldest dosing schedule in the class, and the clearest illustration of what weekly dosing replaced.
Key takeaways
- Molecule: exenatide. Approved for: type 2 diabetes.
- Form: twice-daily injection. Prescription-only, like every product in this class.
Important limitation: This page does not reproduce Byetta’s label. Side-effect rates, contraindications, dosing schedules and interactions belong to the prescribing information, and we link to the class-wide guides rather than paraphrasing a label.
Next action: The label for Byetta is published on DailyMed and is the authority on how it is taken. Separately, here is how Byetta is priced on each route.
Primary sources: DailyMed, U.S. National Library of Medicine, U.S. Food & Drug Administration
General education, not medical advice. This page does not publish dosing instructions.
At a glance
- Molecule
- exenatide
- Approved for
- type 2 diabetes
- Form
- twice-daily injection
- Self-pay, direct from manufacturer
- Not published
- Prescription required
- Yes — as for every GLP-1 receptor agonist
Injected within 60 minutes before the two main meals of the day. It is the oldest dosing schedule in the class, and the clearest illustration of what the weekly products replaced.
The confusion worth clearing up
Bydureon was the extended-release, once-weekly sibling of this drug. We can find no current US prescribing information for it on DailyMed as of 17 August 2026, so we do not describe it as available, and we are not going to state a reason we cannot source.
The class, the molecule and the brand name are three different levels, and most “versus” questions in this category dissolve once they are separated — which level of that Byetta belongs to, and what it is being compared against is the thing worth settling first.
What this page deliberately leaves out
Side-effect rates, contraindications, dosing schedules, and drug interactions for Byetta are on its FDA-approved label, published on DailyMed. We are not going to reproduce them here from anywhere else, because a drug page that looks complete but was assembled second-hand is more dangerous than one that is visibly partial.
What we do cover, at the level of the class rather than the product:
- Side effects — what is common, what is serious, and the boxed warning.
- Dosing and titration — why doses start low and climb, and what happens at each step.
- How these medications work — the four mechanisms, and why they also explain the side effects.
Questions people ask about Byetta
Is Byetta a GLP-1?
Yes. Byetta is exenatide, a GLP-1 receptor agonist, approved for type 2 diabetes and given as a twice-daily injection. "GLP-1" is the drug class; exenatide is the molecule; Byetta is the brand name that molecule is sold under for this use.
Do you need a prescription for Byetta?
Yes, in the United States, as for every GLP-1 receptor agonist. Anything sold as Byetta without a prescription is not Byetta, whatever the label says — and a product bought outside the prescribing chain carries none of the manufacturing verification the approved product does.
How much does Byetta cost?
The manufacturer does not publish a self-pay price for Byetta. Where a price is not published we say so rather than estimate one, so the total for this product depends on the route you take to it.
Before you act on anything here
- Byetta is prescription-only. Anything sold as Byetta without a prescription is not Byetta.
- Take dosing and administration from the label on your own prescription, not from this page or any other.
- Approval status and price are checked on the dates shown and both change — re-verify before relying on either.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: The approved indication and dosage form for Byetta, and the labelled information this page deliberately does not reproduce.
- Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Approval status for Byetta, checkable in Drugs@FDA and the Orange Book.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.